Ticker
EVOKCompany Name
EVOKE PHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 16.06M | $ 641.87K | 4% |
3/31/2025 | $ 16.38M | $ 532.14K | 3.25% |
12/31/2024 | $ 17.52M | $ 445.08K | 2.54% |
9/30/2024 | $ 14.15M | $ 493.41K | 3.49% |
6/30/2024 | $ 12.14M | $ 544.76K | 4.49% |
3/31/2024 | $ 12.45M | $ 588.78K | 4.73% |
12/31/2023 | $ 7.07M | $ 481.84K | 6.82% |
9/30/2023 | $ 7.85M | $ 504.93K | 6.43% |
6/30/2023 | $ 8.98M | $ 513.71K | 5.72% |
3/31/2023 | $ 10.04M | $ 364.87K | 3.63% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for EVOKE PHARMA INC is calculated as follows: Inventory [ $ 86.14K ] / Assets [ $ 6.75M ]
(=) Inv. to Assets [ 1.28% ]
Minimum
Mar 31, 2021
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.08% |
median | 0% |
std | 11.1% |